NHERF1 and neoplasm: The opposite effects of EBP50 in OCCC are in line with evidence that EBP50 is tumor suppressive when localized underneath the plasma membrane, but oncogenic when localized in the cytoplasm or nucleus, or when deleted [17, 31, 37, 38].